Stocks-01093.HK-CSPC Pharmaceutical Group Ltd

01093.HK CSPC Pharmaceutical Group Ltd

6.15 0 (0%)
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: CSPC Pharmaceutical Group Ltd's revenues increased by 7.12% and amounted to 35.98B. Net income increased by 5.71% to 7.25B. Net assets increased by 8.25% to 35.53B and EPS increased from 0.57 to 0.59.
01093.HK's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
70.54%
Net Profit Margin
19.32%
Operating Margin
21.68%
Return On Investment
21.00%